skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: NF-{kappa}B p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells

Abstract

Lung adenocarcinoma Cl1-5 cells were selected from parental Cl1-0 cells based on their high metastatic potential. In a previous study, CRMP-1, an invasion suppressor gene, was shown to be suppressed in Cl1-5 cells. However, the regulation of CRMP-1 expression has not been explored. In this study, we showed nuclear factor-{kappa}B controls CRMP-1 expression. The electromobility shift assay showed that while Cl1-0 cells exhibited low NF-{kappa}B activity in response to TNF-{alpha}, an abundance of basal and TNF-{alpha}-induced NF-{kappa}B-DNA complex was detected in Cl1-5 cells. Supershift-coupled EMSA and Western blotting of nuclear proteins, however, revealed p50 protein, but not classic p65/p50 heterodimer in the complex. ChIP and EMSA demonstrated that p50 binds to a {kappa}B site residing between -1753 and -1743 of the CRMP-1 promoter region. Transfection of antisense p50 gene into Cl1-5 cells increased the CRMP-1 protein level and decreased the invasive activity of Cl1-5 cells.

Authors:
 [1];  [1];  [1];  [1];  [2];  [1]
  1. Cancer Research Center, College of Medicine, National Taiwan University, Taipei, Taiwan (China)
  2. Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan (China)
Publication Date:
OSTI Identifier:
21217096
Resource Type:
Journal Article
Journal Name:
Biochemical and Biophysical Research Communications
Additional Journal Information:
Journal Volume: 376; Journal Issue: 2; Other Information: DOI: 10.1016/j.bbrc.2008.08.144; PII: S0006-291X(08)01669-0; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0006-291X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; CARCINOMAS; CHROMATIN; DNA; GENES; HUMAN POPULATIONS; LUNGS; METASTASES; PROTEINS; REGULATIONS; TUMOR CELLS; TUMOR PROMOTERS

Citation Formats

Ming, Gao, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Yeh, P Y, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, Lu, Y -S, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, ROC, Chang, W C, Kuo, M -L, Cheng, A -L, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, and Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan. NF-{kappa}B p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. United States: N. p., 2008. Web.
Ming, Gao, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Yeh, P Y, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, Lu, Y -S, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, ROC, Chang, W C, Kuo, M -L, Cheng, A -L, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, & Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan. NF-{kappa}B p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. United States.
Ming, Gao, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Yeh, P Y, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, Lu, Y -S, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, ROC, Chang, W C, Kuo, M -L, Cheng, A -L, National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, and Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan. 2008. "NF-{kappa}B p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells". United States.
@article{osti_21217096,
title = {NF-{kappa}B p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells},
author = {Ming, Gao and National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan and Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan and Yeh, P Y and Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan and Lu, Y -S and National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan and Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan, ROC and Chang, W C and Kuo, M -L and Cheng, A -L and National Center of Excellence for Clinical Trial and Research, National Taiwan University, Hospital, Taipei, Taiwan and Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan and Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan and Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 10016, Taiwan},
abstractNote = {Lung adenocarcinoma Cl1-5 cells were selected from parental Cl1-0 cells based on their high metastatic potential. In a previous study, CRMP-1, an invasion suppressor gene, was shown to be suppressed in Cl1-5 cells. However, the regulation of CRMP-1 expression has not been explored. In this study, we showed nuclear factor-{kappa}B controls CRMP-1 expression. The electromobility shift assay showed that while Cl1-0 cells exhibited low NF-{kappa}B activity in response to TNF-{alpha}, an abundance of basal and TNF-{alpha}-induced NF-{kappa}B-DNA complex was detected in Cl1-5 cells. Supershift-coupled EMSA and Western blotting of nuclear proteins, however, revealed p50 protein, but not classic p65/p50 heterodimer in the complex. ChIP and EMSA demonstrated that p50 binds to a {kappa}B site residing between -1753 and -1743 of the CRMP-1 promoter region. Transfection of antisense p50 gene into Cl1-5 cells increased the CRMP-1 protein level and decreased the invasive activity of Cl1-5 cells.},
doi = {},
url = {https://www.osti.gov/biblio/21217096}, journal = {Biochemical and Biophysical Research Communications},
issn = {0006-291X},
number = 2,
volume = 376,
place = {United States},
year = {Fri Nov 14 00:00:00 EST 2008},
month = {Fri Nov 14 00:00:00 EST 2008}
}